Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 52Z52 | — |
Pharmacist realized that after vaccination one of the powder vials (diluent) was not mixed; one of those patients was given an incomplete dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 83-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 52Z52, expiry date 16-OCT-2025) for prophylaxis. On 20-MAR-2025, the patient received Arexvy. On 20-MAR-2025, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: Pharmacist realized that after vaccination one of the powder vials (diluent) was not mixed) and inappropriate dose of vaccine administered (Verbatim: one of those patients was given an incomplete dose). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 20-MAR-2025 The pharmacist asked about guidance on revaccination on two patient that was vaccinated, nevertheless after mixing doses, the pharmacist realized that after vaccination one of the powder vials (diluent) was not mixed and one of those patients was given an incomplete dose. The pharmacist did not know which of this patient was given the incomplete dose. Vaccination date, vaccine detail and patient demographics were obtained in this call. No further information was obtained in this call. The vaccine administration facility was the same as primary reporter.; Sender's Comments: US-GSK-US2025034229:same reporter different patient